Begin main content

Updates to the Therapeutic Review Framework

May 7, 2015
In January 2012 CADTH outlined our process for undertaking Therapeutic Reviews in a Therapeutic Review Framework. Today we have updated this framework to clarify the timing and scope of these reviews, as well as the type of evidence that is considered. These changes are outlined in more detail below. Revised Therapeutic Review Framework: Definit...

CADTH Announces New Vice-President, Pharmaceutical Reviews

May 6, 2015
We are pleased to announce the appointment of Brent Fraser to the position of Vice-President, Pharmaceutical Reviews, effective August 4, 2015. In this role, Brent will be responsible for the CADTH Common Drug Review, the pan-Canadian Oncology Drug Review, and all other aspects of CADTH work in the pharmaceutical space. Brent joins CADTH from th...

pCODR Performance Report

April 21, 2015
CADTH is pleased to issue the second pan-Canadian Oncology Drug Review (pCODR) performance report. Through the pCODR process, CADTH reviews cancer drugs and makes reimbursement recommendations to Canada's provincial and territorial public drug plans –— with the exception of Quebec –— and to provincial cancer agencies. This performance report ana...

What's on the 2015 Canadian Top 10 List of Game-Changing Health Technologies?

April 13, 2015
Five emerging drugs and five new medical devices have been selected as Canada's top 10 new and emerging health technologies by the Canadian Network for Environmental Scanning in Health (CNESH) and a panel of clinical experts. The second annual Top 10 New and Emerging Health Technology Watch List was publicly announced today at the 2015 CADTH Sym...